235 related articles for article (PubMed ID: 11200835)
1. Long-term serological follow-up of patients treated for chronic cutaneous borreliosis or culture-positive erythema migrans.
Lomholt H; Lebech AM; Hansen K; Brandrup F; Halkier-Sørensen L
Acta Derm Venereol; 2000; 80(5):362-6. PubMed ID: 11200835
[TBL] [Abstract][Full Text] [Related]
2. Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis.
Hammers-Berggren S; Lebech AM; Karlsson M; Svenungsson B; Hansen K; Stiernstedt G
J Clin Microbiol; 1994 Jun; 32(6):1519-25. PubMed ID: 8077398
[TBL] [Abstract][Full Text] [Related]
3. Changes in Borrelia burgdorferi-specific serum IgG antibody levels in patients treated for acrodermatitis chronica atrophicans.
Olsson I; Asbrink E; von Stedingk M; von Stedingk LV
Acta Derm Venereol; 1994 Nov; 74(6):424-8. PubMed ID: 7701871
[TBL] [Abstract][Full Text] [Related]
4. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
[TBL] [Abstract][Full Text] [Related]
5. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H
Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807
[TBL] [Abstract][Full Text] [Related]
6. Erythema migrans: three weeks treatment for prevention of late Lyme borreliosis.
Breier F; Kunz G; Klade H; Stanek G; Aberer E
Infection; 1996; 24(1):69-72. PubMed ID: 8852474
[TBL] [Abstract][Full Text] [Related]
7. Serological follow-up after treatment of Borrelia arthritis and acrodermatitis chronica atrophicans.
Hammers-Berggren S; Lebech AM; Karlsson M; Andersson U; Hansen K; Stiernstedt G
Scand J Infect Dis; 1994; 26(3):339-47. PubMed ID: 7939435
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients.
Glatz M; Golestani M; Kerl H; Müllegger RR
Arch Dermatol; 2006 Jul; 142(7):862-8. PubMed ID: 16847202
[TBL] [Abstract][Full Text] [Related]
9. Molecular and serological diagnosis of Borrelia burgdorferi infection among patients with diagnosed Erythema migrans.
Kondrusik M; Grygorczuk S; Skotarczak B; Wodecka B; Rymaszewska A; Pancewicz S; Zajkowska J; Swierzbińska R; Hermanowska-Szpakowicz T
Ann Agric Environ Med; 2007; 14(2):209-13. PubMed ID: 18247452
[TBL] [Abstract][Full Text] [Related]
10. The outcome of Lyme borreliosis in children.
Aberer E; Kehldorfer M; Binder B; Schauperi H
Wien Klin Wochenschr; 1999 Dec; 111(22-23):941-4. PubMed ID: 10666805
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of test with antigen VlsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis].
Zajkowska JM; Kondrusik M; Pancewicz SA; Grygorczuk S; Jamiołkowski J; Stalewska J
Pol Merkur Lekarski; 2007 Aug; 23(134):95-9. PubMed ID: 18044336
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to Borrelia burgdorferi in patients with carpal tunnel syndrome.
Kindstrand E
Acta Neurol Scand; 1992 Jul; 86(1):73-5. PubMed ID: 1519478
[TBL] [Abstract][Full Text] [Related]
13. Comparison of different Borrelia burgdorferi sensu lato strains for detection of immune response in patients with erythema migrans.
Merljak Skocir L; Ruzić-Sabljić E; Maraspin-Carman V; Lotric-Furlan S; Logar M; Strle F
Int J Med Microbiol; 2008 Jul; 298(5-6):493-504. PubMed ID: 17892971
[TBL] [Abstract][Full Text] [Related]
14. Therapy of Lyme borreliosis in children.
Krbkova L; Stanek G
Infection; 1996; 24(2):170-3. PubMed ID: 8740116
[TBL] [Abstract][Full Text] [Related]
15. Solitary erythema migrans: a clinical, laboratory and epidemiological study of 77 Dutch patients.
Kuiper H; Cairo I; Van Dam A; De Jongh B; Ramselaar T; Spanjaard L; Dankert J
Br J Dermatol; 1994 Apr; 130(4):466-72. PubMed ID: 8186111
[TBL] [Abstract][Full Text] [Related]
16. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans.
Aguero-Rosenfeld ME; Nowakowski J; Bittker S; Cooper D; Nadelman RB; Wormser GP
J Clin Microbiol; 1996 Jan; 34(1):1-9. PubMed ID: 8748261
[TBL] [Abstract][Full Text] [Related]
17. [Lymphocyte proliferation test in cutaneous manifestations of Lyme borreliosis].
Breier F; Klade H; Stanek G
Wien Med Wochenschr; 1995; 145(7-8):170-3. PubMed ID: 7610666
[TBL] [Abstract][Full Text] [Related]
18. Comparison of flagellum and sonicate antigens for serological diagnosis of Lyme borreliosis.
Karlsson M; Stiernstedt G; Granström M; Asbrink E; Wretlind B
Eur J Clin Microbiol Infect Dis; 1990 Mar; 9(3):169-77. PubMed ID: 2186910
[TBL] [Abstract][Full Text] [Related]
19. [Early diagnosis of Lyme borreliosis].
Hofmann H
MMW Fortschr Med; 2006 Jun; 148(25):32, 34, 36. PubMed ID: 16859158
[TBL] [Abstract][Full Text] [Related]
20. Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease.
Hunfeld KP; Ernst M; Zachary P; Jaulhac B; Sonneborn HH; Brade V
Wien Klin Wochenschr; 2002 Jul; 114(13-14):580-5. PubMed ID: 12422605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
